Vanguard Personalized Indexing Management, LLC Nuvation Bio Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 36,486 shares of NUVB stock, worth $134,998. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,486
Previous 30,179
20.9%
Holding current value
$134,998
Previous $53,000
33.96%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding NUVB
# of Institutions
195Shares Held
168MCall Options Held
2.31MPut Options Held
221K-
Decheng Capital LLC Menlo Park, CA26MShares$96 Million12.78% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$60.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.9MShares$58.8 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA11MShares$40.9 Million46.36% of portfolio
-
Laurion Capital Management LP New York, NY10.2MShares$37.9 Million0.37% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $804M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...